Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 51, 2021 - Issue 15
246
Views
0
CrossRef citations to date
0
Altmetric
Articles

Kemp-type elimination of 1-arylsulfonyl-3-iodo-1H-indazoles

, , &
Pages 2365-2376 | Received 05 Jan 2021, Published online: 21 Jun 2021

References

  • Casey, M. L.; Kemp, D. S.; Paul, K. G.; Cox, D. D. Physical Organic Chemistry of Benzisoxazoles. I. Mechanism of the Base-Catalyzed Decomposition of Benzisoxazoles. J. Org. Chem. 1973, 38, 2294–2301. DOI: 10.1021/jo00953a006.
  • Zhang, S.; Zhang, J.; Zhu, Y. ProdaMatch: A Fast and Accurate Active Site Matching Algorithm for de Novo Enzyme Design. Comput. Chem. Eng. 2020, 140, 106921. DOI: 10.1016/j.compchemeng.2020.106921.
  • Welborn, V. V.; Ruiz Pestana, L.; Head-Gordon, T. Ruiz Pestana. Nat. Catal. 2018, 1, 649–655. DOI: 10.1038/s41929-018-0109-2.
  • Röthlisberger, D.; Khersonsky, O.; Wollacott, A. M.; Jiang, L.; DeChancie, J.; Betker, J.; Gallaher, J. L.; Althoff, E. A.; Zanghellini, A.; Dym, O.; et al. Nature 2008, 453, 190. DOI: 10.1038/nature06879.
  • Privett, H. K.; Kiss, G.; Lee, T. M.; Blomberg, R.; Chica, R. A.; Thomas, L. M.; Hilvert, D.; Houk, K. N.; Mayo, S. L. Iterative Approach to Computational Enzyme Design. Proc. Natl. Acad. Sci. USA 2012, 109, 3790–3795. DOI: 10.1073/pnas.1118082108.
  • Li, Y.; Barløse, C.; Jørgensen, J.; Carlsen, B. D.; Jørgensen, K. A. Cover Picture: Asymmetric Catalytic Aza-Diels-Alder/Ring-Closing Cascade Reaction Forming Bicyclic Azaheterocycles by Trienamine Catalysis (Chem. Eur. J. 1/2017). Chem. Eur. J. 2017, 23, 1–1. DOI: 10.1002/chem.201605561.
  • Labas, A.; Szabo, E.; Mones, L.; Fuxreiter, M. Biochim. Biophys. Acta Proteins Proteom. 2013, 1834, 908–917. DOI: 10.1016/j.bbapap.2013.01.005.
  • Khersonsky, O.; Kiss, G.; Röthlisberger, D.; Dym, O.; Albeck, S.; Houk, K. N.; Baker, D.; Tawfik, D. S. Bridging the Gaps in Design Methodologies by Evolutionary Optimization of the Stability and Proficiency of Designed Kemp Eliminase KE59. Proc. Natl. Acad. Sci. USA 2012, 109, 10358–10363. DOI: 10.1073/pnas.1121063109.
  • Jindal, G.; Ramachandran, B.; Bora, R. P.; Warshel, A. Exploring the Development of Ground-State Destabilization and Transition-State Stabilization in Two Directed Evolution Paths of Kemp Eliminases. ACS Catal. 2017, 7, 3301–3305. DOI: 10.1021/acscatal.7b00171.
  • Frushicheva, M. P.; Cao, J.; Warshel, A. Challenges and Advances in Validating Enzyme Design Proposals: The Case of Kemp Eliminase Catalysis. Biochemistry 2011, 50, 3849–3858. DOI: 10.1021/bi200063a.
  • Bunzel, H. A.; Kries, H.; Marchetti, L.; Zeymer, C.; Mittl, P. R. E.; Mulholland, A. J.; Hilvert, D. Emergence of a Negative Activation Heat Capacity during Evolution of a Designed Enzyme. J. Am. Chem. Soc. 2019, 141, 11745–11748. DOI: 10.1021/jacs.9b02731.
  • Blomberg, R.; Kries, H.; Pinkas, D. M.; Mittl, P. R. E.; Grütter, M. G.; Privett, H. K.; Mayo, S. L.; Hilvert, D. Nature 2013, 503, 418. DOI: 10.1038/nature12623.
  • Bhowmick, A.; Sharma, S. C.; Head-Gordon, T. The Importance of the Scaffold for de Novo Enzymes: A Case Study with Kemp Eliminase. J. Am. Chem. Soc. 2017, 139, 5793–5800. DOI: 10.1021/jacs.6b12265.
  • Li, A.; Wang, B.; Ilie, A.; Dubey, K. D.; Bange, G.; Korendovych, I. V.; Shaik, S.; Reetz, M. T. Nat. Commun. 2017, 8, 14876. DOI: 10.1038/ncomms14876.
  • Sakamoto, S.; Komatsu, T.; Ueno, T.; Hanaoka, K.; Urano, Y. Fluorescence Detection of Serum Albumin with a Turnover-Based Sensor Utilizing Kemp Elimination Reaction. Bioorg. Med. Chem. Lett. 2017, 27, 3464–3467. DOI: 10.1016/j.bmcl.2017.05.076.
  • Lamba, V.; Sanchez, E.; Fanning, L. R.; Howe, K.; Alvarez, M. A.; Herschlag, D.; Forconi, M. Kemp Eliminase Activity of Ketosteroid Isomerase. Biochemistry 2017, 56, 582–591. DOI: 10.1021/acs.biochem.6b00762.
  • Acosta-Silva, C.; Bertran, J.; Branchadell, V.; Oliva, A. Kemp Elimination Reaction Catalyzed by Electric Fields. ChemPhysChem. 2020, 21, 295–306. DOI: 10.1002/cphc.201901155.
  • Zheng, D.; Asano, Y. Biocatalytic Asymmetric Ring-Opening of Dihydroisoxazoles: A Cyanide-Free Route to Complementary Enantiomers of β-Hydroxy Nitriles from Olefins. Green Chem. 2020, 22, 4930–4936. DOI: 10.1039/D0GC01445A.
  • Zhao, S.; Chen, Z.-L.; Rui, X.; Gao, M.-M.; Chen, X. Asymmetric Allylic Amination of Morita–Baylis–Hillman Adducts with Simple Aromatic Amines by Nucleophilic Amine Catalysis. Synlett. 2019, 30, 703–708. DOI: 10.1055/s-0037-1611828.
  • Eriksen, B. L.; Vedsø, P.; Morel, S.; Begtrup, M. Synthesis of 2-Substituted 1-Hydroxyimidazoles through Directed Lithiation. J. Org. Chem. 1998, 63, 12–16. DOI: 10.1021/jo970355+.
  • Ogamino, T.; Obata, R.; Nishiyama, S. Asymmetric Synthesis of Aerothionin, a Marine Dimeric Spiroisoxazoline Natural Product, Employing Optically Active Spiroisoxazoline Derivative. Tetrahedron Lett. 2006, 47, 727–731. DOI: 10.1016/j.tetlet.2005.11.097.
  • Weyler, S.; Hayallah, A. M.; Müller, C. E. Versatile, Convenient Synthesis of Pyrimido[1,2,3-Cd]Purinediones. Tetrahedron 2003, 59, 47–54. DOI: 10.1016/S0040-4020(02)01485-0.
  • Nagaradja, E.; Chevallier, F.; Roisnel, T.; Dorcet, V.; Halauko, Y. S.; Ivashkevich, O. A.; Matulis, V. E.; Mongin, F. Deproto-Metallation Using a Mixed Lithium–Zinc Base and Computed CH Acidity of 1-Aryl 1H-Benzotriazoles and 1-Aryl 1H-Indazoles. Org. Biomol. Chem. 2014, 12, 1475. DOI: 10.1039/c3ob42380h.
  • Hattori, K.; Yamaguchi, K.; Yamaguchi, J.; Itami, K. Pd- and Cu-Catalyzed C–H Arylation of Indazoles. Tetrahedron 2012, 68, 7605–7612. DOI: 10.1016/j.tet.2012.05.091.
  • Bunnell, A.; O'Yang, C.; Petrica, A.; Soth, M. Convenient Method for the 3-Functionalization of Isoindazoles. J. Synth. Commun. 2006, 36, 285–293. DOI: 10.1080/00397910500376570.
  • Blair, V. L.; Blakemore, D. C.; Hay, D.; Hevia, E.; Pryde, D. C. Alkali-Metal Mediated Zincation of N-Heterocyclic Substrates Using the Lithium Zincate Complex, (THF)Li(TMP)Zn(tBu)2 and Applications in in Situ Cross Coupling Reactions. Tetrahedron Lett. 2011, 52, 4590–4594. DOI: 10.1016/j.tetlet.2011.06.090.
  • Tang, M.; Chu, B.; Chang, X. Direct N-Alkylation and Kemp Elimination Reactions of 1-Sulfonyl-1H-Indazoles. Chem. Asian J. 2018, 13, 2109–2116. DOI: 10.1002/asia.201800741.
  • Sleebs, B. E.; Levit, A.; Street, I. P.; Falk, H.; Hammonds, T.; Wong, A. C.; Charles, M. D.; Olson, M. F.; Baell, J. B. Identification of 3-Aminothieno[2,3-b]Pyridine-2-Carboxamides and 4-Aminobenzothieno[3,2-d]Pyrimidines as LIMK1 Inhibitors. Med. Chem. Commun. 2011, 2, 977. DOI: 10.1039/c1md00137j.
  • Wen, H.; Cao, W.; Liu, Y.; Wang, L.; Chen, P.; Tang, Y. Metal-Free [2 + 2 + 2] Cycloaddition of Ynamide–Nitriles with Ynamides: A Highly Regio- and Chemoselective Synthesis of δ-Carboline Derivatives. J. Org. Chem. 2018, 83, 13308–13324. DOI: 10.1021/acs.joc.8b02112.
  • Okuda, K.; Zhang, Y.-X.; Hirota, T.; Sasaki, K. Polycyclic N-Heterocyclic Compounds. Part 85: Synthesis and Evaluation of Antiplatelet Aggregation Activity of 2,4-Disubstituted 5,6-Dihydro[1]Benzazepino[5,4-d]Pyrimidine and Related Compounds. J. Heterocyclic Chem. 2015, 52, 888–895. DOI: 10.1002/jhet.2040.
  • Harris, P. A.; Boloor, A.; Cheung, M.; Kumar, R.; Crosby, R. M.; Davis-Ward, R. G.; Epperly, A. H.; Hinkle, K. W.; Hunter, R. N.; Johnson, J. H.; et al. Discovery of 5-[[4-[(2,3-Dimethyl-2H-Indazol-6-yl)Methylamino]-2-Pyrimidinyl]Amino]-2-Methyl-Benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor. J. Med. Chem. 2008, 51, 4632–4640. DOI: 10.1021/jm800566m.
  • Jones, P.; Altamura, S.; Boueres, J.; Ferrigno, F.; Fonsi, M.; Giomini, C.; Lamartina, S.; Monteagudo, E.; Ontoria, J. M.; Orsale, M. V.; et al. Discovery of 2-{4-[(3 S)-Piperidin-3-yl]Phenyl}-2 H-Indazole-7-Carboxamide (MK-4827): A Novel Oral Poly(ADP-Ribose)Polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors. J. Med. Chem. 2009, 52, 7170–7185. DOI: 10.1021/jm901188v.
  • Sanger, G. J.; Nelson, D. R. Selective and Functional 5-hydroxytryptamine3 Receptor Antagonism by BRL 43694 (Granisetron). Eur. J. Pharmacol. 1989, 159, 113–124. DOI: 10.1016/0014-2999(89)90695-X.
  • Cerecetto, H.; Gerpe, A.; Gonzalez, M.; Aran, V. J.; de Ocariz, C. O. Pharmacological Properties of Indazole Derivatives: Recent Developments. Mini-Rev. Med. Chem.. 2005, 5, 869–878. DOI: 10.2174/138955705774329564.
  • Gaikwad, D. D.; Chapolikar, A. D.; Devkate, C. G.; Warad, K. D.; Tayade, A. P.; Pawar, R. P.; Domb, A. J. Synthesis of Indazole Motifs and Their Medicinal Importance: An Overview. Eur. J. Med. Chem. 2015, 90, 707–731. DOI: 10.1016/j.ejmech.2014.11.029.
  • Hu-Lowe, D. D.; Zou, H. Y.; Grazzini, M. L.; Hallin, M. E.; Wickman, G. R.; Amundson, K.; Chen, J. H.; Rewolinski, D. A.; Yamazaki, S.; Wu, E. Y.; et al. Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3. Clin. Cancer Res. 2008, 14, 7272–7283. DOI: 10.1158/1078-0432.CCR-08-0652.
  • Gilbert, J. A.; Adhikari, L. J.; Lloyd, R. V.; Halfdanarson, T. R.; Muders, M. H.; Ames, M. M. Pancreas 2013, 42, 411. DOI: 10.1097/MPA.0b013e31826cb243.
  • Cohen, E. E. W.; Rosen, L. S.; Vokes, E. E.; Kies, M. S.; Forastiere, A. A.; Worden, F. P.; Kane, M. A.; Sherman, E.; Kim, S.; Bycott, P.; et al. Axitinib is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results from a Phase II Study. J. Clin. Oncol.. 2008, 26, 4708–4713. DOI: 10.1200/JCO.2007.15.9566.
  • Fujii, Y.; Tanaka, H.; Toyooka, H. Acta Anaesthesiol. Scand. 2013, 57, 533.
  • Hung, N. K.; Wu, C. T.; Chan, S. M.; Lu, C. H.; Huang, Y. S.; Yeh, C. C.; Lee, M. S.; Cherng, C. H. Anesth. Analg. 2010, 111, 882.
  • Epstein, J. B.; Stevenson-Moore, P.; Jackson, S.; Mohamed, J. H.; Spinelli, J. J. Prevention of Oral Mucositis in Radiation Therapy: A Controlled Study with Benzydamine Hydrochloride Rinse. Int. J. Radiat. Oncol. Biol. Phys. 1989, 16, 1571–1575. [Database] DOI: 10.1016/0360-3016(89)90964-4.
  • Kong, K.; Zhang, J.; Liu, B.; Meng, G.; Zhang, Q. Discovery of 5-(Pyridin-3-yl)-1H-Indole-4,7-Diones as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. Bioorg. Med. Chem. Lett. 2020, 30, 126901. DOI: 10.1016/j.bmcl.2019.126901.
  • Vera, G.; Diethelm, B.; Terraza, C. A.; Recabarren-Gajardo, G. Suzuki-Type Cross-Coupling Reaction of Unprotected 3-Iodoindazoles with Pinacol Vinyl Boronate: An Expeditive C-3 Vinylation of Indazoles under Microwave Irradiation. Molecules 2018, 23, 2051. DOI: 10.3390/molecules23082051.
  • Arnautu, A.; Collot, V.; Ros, J. C.; Alayrac, C.; Witulski, B.; Rault, S. Sonogashira Cross-Coupling Reaction of 3-Iodoindazoles with Various Terminal Alkynes: A Mild and Flexible Strategy to Design 2-Aza Tryptamines. Tetrahedron Lett. 2002, 43, 2695–2697. DOI: 10.1016/S0040-4039(02)00393-3.
  • Collot, V.; Varlet, D.; Rault, S. Heck Cross-Coupling Reaction of 3-Iodoindazoles with Methyl Acrylate: A Mild and Flexible Strategy to Design 2-Aza Tryptamines. Tetrahedron Lett. 2000, 41, 4363–4366. DOI: 10.1016/S0040-4039(00)00624-9.
  • Imperato, G.; Vasold, R.; König, B. Stille Reactions with Tetraalkylstannanes and Phenyltrialkylstannanes in Low Melting Sugar-Urea-Salt Mixtures. Adv. Synth. Catal. 2006, 348, 2243–2247. DOI: 10.1002/adsc.200600248.
  • Langer, O.; Forngren, T.; Sandell, J.; Dollé, F.; Långström, B.; Någren, K.; Halldin, C. Preparation of 4-[11C]Methylmetaraminol, a Potential PET Tracer for Assessment of Myocardial Sympathetic Innervation. J. Label. Compd. Radiopharm. 2003, 46, 55–65. DOI: 10.1002/jlcr.642.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.